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To the Editor,
We have read with great interest the 
recently published article by Lenicek et al. 
(2010) on the importance of the determi-
nation of bile acid malabsorption (BAM) 
in inflammatory bowel diseases (IBD). The 
authors suggest that BAM may occur in over 
40% of patients with Crohn’s disease (CD) 
and that routine measurements of BAM 
should be incorporated in the diagnostic 
algorithm of CD. However, it is question-
able whether BAM is really a CD-specific 
alteration or simply is a consequence of the 
ileal resection? If we further analyze the data 
of Lenicek et al. (2010) we can calculate that 
abnormal serum C4 level was observed in 
67% (103 of 167) of the resected patients, 
whereas BAM developed in only 12% (13 
of 109) of the non-resected CD patients. 
BAM occurred more frequently (87%) in 
case of more extensive resection. On the 
basis of these data, it might be concluded 
that the development of BAM rather 
depends on a condition caused by shorter 
small bowel than a CD-specific alteration. 
On the basis of the observation that BAM 
occurred in 11% of patients with colonic 
and in 14% of patients with non-resected 
ileal CD also confirm that the location of 
CD really does not matter in this context. 
Our opinion is that the theoretical associa-
tion between the ileal inflammation and the 
impaired function of the ileal sodium/bile 
acid transporter (ASBT) does not work in 
the clinical routine. This is in accordance 
with the results of Holzer et al. (2008), 
who reported that diminished expression 
of ASBT mRNA in non-obese patients 
with gallstones is independent from ileal 
inflammation. Lenicek et al. (2010) also 
concluded that BAM can not be predicted 
based solely on clinical data. We agree with 
this observation, since the development of 
clinical symptoms is the consequence of a 
very complex mechanism. It is well known 
that the leading symptom of CD, namely 
watery diarrhea, is not only observed 
after small bowel resection, but it is also 
very common in patients who underwent 
cholecystectomy. Importantly, cholesty-
ramine, a polymeric bile acid sequestrant, 
lowers the concentration of bile acids and 
ameliorates the diarrhea in these patients 
(Hofmann and Poley, 1972). These clini-
cal data strongly suggest that bile acids are 
involved in the development of diarrhea in 
the case of BAM.
It is known that ion transporters are 
involved in the development of diarrhea 
in IBD. The impaired activities of ion 
transporters are usually characterized by 
increased Cl
− secretion and/or inhibited 
Cl− and Na+ absorption. Importantly, these 
transport mechanisms have been found to 
be influenced by bile salts in the gastrointes-
tinal tract (Mauricio et al., 2000; Venglovecz 
et al., 2008; Goldman et al., 2010). In pan-
creatic (Venglovecz et al., 2008) and esopha-
geal (Goldman et al., 2010) epithelial cells, 
bile acids, in millimolar concentration, 
inhibited Na+/H+ exchangers. In colono-
cytes, bile acids inhibited amiloride sensitive 
Na+ (Hofmann and Poley, 1972) and water 
absorption, moreover, induced Cl− (Mekjian 
et al., 1971; Hofmann and Poley, 1972) and 
water (Mekjian et al., 1971) secretion. All of 
these effects in the colon will enhance fecal 
water content and thus augment diarrhea. 
Therefore, BAM, which definitely occurs 
more frequently in resected ileal CD than 
in the non-resected ones, will aggravate 
the disease.
The incidence of gallstones is elevated by 
about twofold in CD (14.35/1000 person/
year vs. 7.75 in matched controls; Parente 
et al., 2007). Should asymptomatic CD 
patients with BAM be treated in order to 
prevent gallstones? Probably yes, if BAM 
would be the unique factor which leads to 
increased gallstone morbidity. However, it 
seems that this process – as every other – is 
multifactorial: the localization and duration 
of CD, number of recurrences and previous 
hospitalizations, extensive resections and 
multiple total parenteral nutrition treat-
ments also increase the risk of gallstone 
development without BAM.
Finally, should BAM be routinely meas-
ured? Nowadays, 61% of the responded 
experts had never used BAM measurements 
(neither did we). However, the publication 
of Lenicek et al. (2010) convinced us that 
the examination of BAM can indeed be 
useful in selected cases: CD patients with 
unexplainable diarrhea and in the case of 
relatively short small bowel resection.
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